Alerta De Seguridad para Trade Name: VENTILATION SYSTEM 840 # Registration: 10349000386 -. Risk Class: III - HIGH RISK # MODELS 4-072214-00; G-062010-00. The series under risk in Brazil and the respective client are in Annex 1.

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por AUTO SUTURE DO BRASIL LTDA.; COVIDIEN LLC.; NELLCOR PURITAN BENNETT IRELAND.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    1355
  • Fecha
    2014-02-14
  • País del evento
  • Fuente del evento
    ANVISA
  • URL de la fuente del evento
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    Complaints have been received from clients in which they declare that the O2 sensor inside the ventilator is not working and that they need to move a patient from one ventilator to another surrogate mechanical ventilation. • If a sensor becomes nonfunctional during use and can not be recalibrated, an external oxygen monitoring device with oxygen alarm capability may be required to monitor the supplied oxygen level of the ventilator and provide the appropriate alarms. o A non-functional O2 sensor does not affect the oxygen concentration supplied by the fan and does not control the flow of gases. • If a sensor becomes non-functional and the institution's protocol requires the transfer of a patient to a surrogate ventilator, the patient should be clinically evaluated to determine the best transfer conditions to reduce patient risk. - According to information of the company the Field Action was completed.
  • Causa
    Conflicting information was provided to puritan bennett 840 fan customers in an addendum to the label (p / n 066009a 09/02) stating that the oxygen sensor should be replaced every two years. the correct operational life is one year from the manufacturing date, as stated in the puritan bennett 840 fan operator's manual. the sensor, p / n 4-072214-00, must not be used after the expiration date printed on the oxygen sensor packaging. puritan bennett 700 series fan operator and service manuals also state that the oxygen sensor should be replaced every two years. the sensor, p / n g-062010-00, should not be used after the expiration date printed on the oxygen sensor package.
  • Acción
    Company is submitting to its customers document with label update (Annex 2)

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    ANVSANVISA